Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Akari Therapeutics Appoints Vatnak Vat-Ho as Chief Business Officer

PUBLIC · AKTXOct 14, 2026

Position

Chief Business Officer

Company

Akari Therapeutics

Vatnak Vat-Ho
TampaBiotechnologyresearch

Description

Akari Therapeutics has announced the appointment of Vatnak Vat-Ho as Chief Business Officer, bringing over 20 years of experience in oncology business development and biopharmaceutical strategy. His expertise in structuring collaborations and transaction oversight is expected to enhance the company's strategic initiatives.

Company Information

Company

Akari Therapeutics

Location

401 EAST JACKSON STREET

Tampa, Florida, United States

About

Akari Therapeutics is an oncology biotech company developing novel antibody drug conjugates (ADCs) with its first payload, PH1, a spliceosome modulator that disrupts RNA splicing in cancer cells. Unlike traditional ADC payloads, PH1 induces cancer cell death while activating immune responses, showing robust and durable activity in preclinical models.

Fundz sees it the moment Akari Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Mark
Likely contact at this company
••••••••@••••••••

See Mark's verified email →

Claire
Senior decision-maker at this company
••••••••@••••••••

See Claire's verified email →

John
Senior decision-maker at this company
••••••••@••••••••

See John's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Akari Therapeutics's next move

Learn about Strategic plan

Akari Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.